| Document Date: 2009-03-31 14:49:13
Open Document File Size: 550,01 KBShare Result on Facebook
Company Amgen Inc / Three-Times Weekly / / Country United States / / Event FDA Phase / / IndustryTerm Treatment of Anemia in Cancer / therapeutic biologic products / Treatment of Anemia of Chronic Renal Failure / / MedicalCondition tumor / anemic cancer / iron deficiency / deep venous thromboses / Cancer / chronic renal failure / deep venous thrombosis / Chronic / erythropoietin deficiency / severe anemia / fatigue / AIDS / TUMOR PROGRESSION Renal failure / end-stage renal disease / renal failure / intercurrent infectious/inflammatory / renal dysfunction / anemia / symptomatic anemia / / MedicalTreatment red blood cell transfusions / peritoneal dialysis / hemodialysis / concomitant therapy / chemotherapy / radiotherapy / kidney transplantation / Surgery / dialysis / blood transfusions / / Organization DOSAGE AND ADMINISTRATION / FDA / BOXED WARNINGS and DOSAGE AND ADMINISTRATION / / Product Zidovudine / FOR INJECTION / cisplatin / sodium chloride / AUC0-168h / PROCRIT® / / ProvinceOrState South Carolina / / Technology Pharmacokinetics / chemotherapy / transplantation / recombinant DNA technology / dialysis / /
SocialTag |
Procrit Label Epogen Label FDA Approved: [removed]PROCRIT® (Epoetin alfa)